VKTX Viking Therapeutics, Inc.: institutional ownership and insider trading
468 funds reported holding $3.74B of Viking Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $188M, with 67 new positions and 48 funds selling out; over the last 12 months insiders bought $150K and sold $22.3M on the open market; over its last four quarters it reported revenue of $0 and net income of −$535M.
VKTX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$128M, EPS -1.10
- Quarter ended Mar 31, 2026: revenue $0, net income −$158M, EPS -1.37
- Quarter ended Dec 31, 2025: revenue $0, net income −$158M, EPS -1.39
- Quarter ended Sep 30, 2025: revenue $0, net income −$90.8M, EPS -0.81
Famous investors holding VKTX
- Two Sigma (Two Sigma Investments): $154M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $65.6M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $104M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $20.1M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $3.43M, 0.0% of the portfolio
Largest institutional holders of VKTX
- VANGUARD GROUP INC — $351M
- FMR LLC — $247M
- BlackRock, Inc. (BLK) — $241M
- STATE STREET CORP (STT, STT-PG) — $219M
- VANGUARD CAPITAL MANAGEMENT LLC — $197M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $191M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $175M
- TWO SIGMA INVESTMENTS, LP — $154M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $136M
- CITADEL ADVISORS LLC — $104M
Recent VKTX insider trades
- Jul 29, 2026: Mancini Marianna sold 18,217 shares ($610K)
- Jul 29, 2026: Zante Greg sold 21,217 shares ($710K)
- Jul 29, 2026: Lian Brian sold 148,517 shares ($4.95M)
- Mar 10, 2026: Aubuchon Neil William bought 4,475 shares ($150K)
5%+ owners
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Apr 30, 2026)
Who owns the most VKTX stock?
The largest institutional holders of Viking Therapeutics, Inc. in the latest 13F filings are VANGUARD GROUP INC ($351M), FMR LLC ($247M), BlackRock, Inc. (BLK) ($241M).
Are insiders buying or selling VKTX?
Over the last 12 months insiders bought $150K and sold $22.3M of Viking Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own VKTX?
Two Sigma, D. E. Shaw, Ken Griffin, Izzy Englander, Ray Dalio.
What was VKTX's revenue last quarter?
Viking Therapeutics, Inc. reported revenue of $0 for the quarter ended June 30, 2026, with net income of −$128M.
Which ETFs hold VKTX?
36 ETFs and mutual funds hold it among their top 100 positions, including XBI, ACILX, FACGX, FHCLX.